Open Government Portal

Open Data Portal Catalogue Dataset
Found 38110 records

Notice of Compliance with Conditions - Qualifying Notice.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Imfinzi NOC with Conditions qualifying notice

Notice of Compliance with Conditions - Qualifying Notice

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Prochymal NOC with Conditions qualifying notice

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL).

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Esomeprazole notice notice of intent notify prescription drug list PDL nonprescription status

The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List (PDL).

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Hydrocortisone notice notice of amendment prescription drug list PDL revised listing

The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Hydroquinone notice notice of amendment prescription drug list PDL revised listing

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Ibuprofen to nonprescription status for human use by modifying the Human Prescription Drug List (PDL). The Veterinary List will remain unchanged.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: notice of amendment Prescription Drug List PDL Ibuprofen only human PDL revised listing nonprescription status

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on the Prescription Drug List (PDL). Only the Human part of the PDL was revised; the listing for Veterinary use will remain unchanged.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Levonorgestrel notice notice of amendment prescription drug list PDL revised listing nonprescription status human use Human Prescription Drug-List Veterinary use unchanged

The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List (PDL). As stated in the Notice of Intent to Amend, posted June 4, 2014, the revision will allow lovastatin to be marketed as a nonprescription product. Only the Human part of the PDL has been revised.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Lovastatin notice notice of amendment prescription drug list PDL revised listing nonprescription status human use Human Prescription Drug-List Veterinary use unchanged

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Mometasone furoate notice notice of amendment prescription drug list PDL revised listing nonprescription status human use Human Prescription Drug-List

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Polymyxin B to prescription status for veterinary use by adding it to the Veterinary Prescription Drug List (PDL).

Last Updated: Sep 28, 2023
Date Published: Sep 27, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Polymyxin B notice notice of amendment prescription drug list PDL prescription status veterinary use Veterinary Prescription Drug-List